PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma

Biochemical and Biophysical Research Communications

Volumn 463, Issue 4, 2015, Pages 839-845

  Wang, Jiajun ^a   Shao, Miaomiao ^a   Liu, Min ^a   Peng, Peike ^a   Li, Lili ^a   Wu, Weicheng ^a   Wang, Lan ^a   Duan, Fangfang ^a   Zhang, Mingming ^a   Song, Shushu ^a   Jia, Dongwei ^a   Ruan, Yuanyuan ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

DUOX2; Hepatocellular carcinoma; PKC ; Reactive oxygen species

Indexed keywords

DUOX2 ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA I; PROTEIN KINASE C BETA II; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; DUOX2 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ENZYMOLOGY; GENETICS; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; LIVER NEOPLASMS; NADPH OXIDASE; PROTEIN KINASE C-ALPHA; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 84936986307     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.06.021     Document Type: Article

References (37)

1. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal Global Cancer Statistics, 2012 CA Cancer J. Clin. 65 2015 87 108
2. D. Schottenfeld, and J.F. Fraumeni Cancer Epidemiology and Prevention third ed. 2006 Oxford University Press Oxford; New York
3. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
4. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, A.K. Burroughs, E. Christensen, L. Pagliaro, M. Colombo, and J. Rodes E.P.E. HCC, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference J. Hepatol. 35 2001 421 430
5. Y. Nishizuka Protein kinases.5. Protein-Kinase-C and lipid signaling for sustained cellular-responses Faseb J. 9 1995 484 496
6. E.M. Griner, and M.G. Kazanietz Protein kinase C and other diacylglycerol effectors in cancer Nat. Rev. Cancer 7 2007 281 294
7. S. Nakashima Protein kinase C alpha (PKC alpha): regulation and biological function J. Biochem. 132 2002 669 675
8. C.A. Obrian, V.G. Vogel, S.E. Singletary, and N.E. Ward Elevated protein kinase-C expression in human-breast tumor-biopsies relative to normal breast-tissue Cancer Res. 49 1989 3215 3217
9. G.P. Perletti, C. Smeraldi, D. Porro, and F. Piccinini Involvement of the alpha-isoenzyme of protein-kinase-C in the growth-inhibition induced by phorbol esters in Mh1c1 hepatoma-cells Biochem. Biophys. Res. Commun. 205 1994 1589 1594
10. P. Henttu, and P. Vihko The protein kinase C activator, phorbol ester, elicits disparate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells Biochem. Biophys. Res. Commun. 244 1998 167 171
11. T.T. Wu, Y.H. Hsieh, C.C. Wu, Y.S. Hsieh, C.Y. Huang, and J.Y. Liu Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis Clin. Chim. Acta 382 2007 54 58
12. V.J. Thannickal, and B.L. Fanburg Reactive oxygen species in cell signaling Am. J. Physiol. Lung Cell. Mol. Physiol. 279 2000 L1005 L1028
13. R.A. Cairns, I.S. Harris, and T.W. Mak Regulation of cancer cell metabolism Nat. Rev. Cancer 11 2011 85 95
14. M. Schieber, and N.S. Chandel ROS function in redox signaling and oxidative stress Curr. Biol. 24 2014 R453 R462
15. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189
16. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol. Rev. 87 2007 245 313
17. G.K. Lonne, L. Cornmark, I.O. Zahirovic, G. Landberg, K. Jirstrom, and C. Larsson PKC alpha expression is a marker for breast cancer aggressiveness Mol. Cancer 9 2010
18. Y.Y. Ruan, L.L. Sun, Y.Q. Hao, L.J. Wang, J.J. Xu, W. Zhang, J.H. Xie, L. Guo, L. Zhou, X.J. Yun, H.G. Zhu, A.G. Shen, and J.X. Gu Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma J. Clin. Invest. 122 2012 2554 2566
19. G.Y. Liou, and P. Storz Reactive oxygen species in cancer Free Radic. Res. 44 2010 479 496
20. R. Coriat, C. Nicco, C. Chereau, O. Mir, J. Alexandre, S. Ropert, B. Weill, S. Chaussade, F. Goldwasser, and F. Batteux Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo Mol. Cancer Ther. 11 2012 2284 2293
21. Q.X. Ling, W. Shi, C. Huang, J.M. Zheng, Q. Cheng, K.K. Yu, S.S. Chen, H. Zhang, N. Li, and M.Q. Chen Epigenetic silencing of dual oxidase 1 by promoter hypermethylation in human hepatocellular carcinoma Am. J. Cancer Res. 4 2014 508 517
22. S. De Minicis, T. Kisseleva, H. Francis, G.S. Baroni, A. Benedetti, D. Brenner, D. Alvaro, G. Alpini, and M. Marzioni Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma Dig. Liver Dis. 45 2013 450 459
23. J.-H. Kang Protein kinase C (PKC) isozymes and cancer New J. Sci. 2014 2014 1 36
24. C.Y. Fan, M. Katsuyama, and C. Yabe-Nishimura PKC delta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKC delta in vascular hypertrophy Biochem. J. 390 2005 761 767
25. N. Osawa, T. Hayashi, T. Uzu, T. Babazono, S. Babazono, Y. Iwamoto, A. Kashiwagi, and S. Maeda High glucose-induced activation of PKC epsilon decreases the expression of bone morphogenetic protein 4 (Bmp4) and NADPH oxidase 4 (Nox4) through MAPK-dependent pathway in cultured mouse mesangial cells Diabetes 56 2007 A200-A200
26. E. Migliaccio, M. Giorgio, S. Mele, G. Pelicci, P. Reboldi, P.P. Pandolfi, L. Lanfrancone, and P.G. Pelicci The p66shc adaptor protein controls oxidative stress response and life span in mammals Nature 402 1999 309 313
27. W.S. Wu, R.K. Tsai, C.H. Chang, S. Wang, J.R. Wu, and Y.X. Chang Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2 Mol. Cancer Res. 4 2006 747 758
28. S. Rigutto, C. Hoste, H. Grasberger, M. Milenkovic, D. Communi, J.E. Dumont, B. Corvilain, F. Miot, and X. De Deken Activation of Dual Oxidases Duox1 and Duox2 differential regulation mediated by camp-dependent protein kinase and protein kinase c-dependent phosphorylation J. Biol. Chem. 284 2009 6725 6734
29. F. Chen, Y. Yu, S. Haigh, J. Johnson, R. Lucas, D.W. Stepp, and D.J. Fulton Regulation of NADPH oxidase 5 by protein kinase C isoforms PLoS One 9 2014 e88405
30. A.R. Hanauske, K. Sundell, and M. Lahn The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PWC-alpha-specific inhibitor aprinocarsen Curr. Pharm. Des. 10 2004 1923 1936
31. T.T. Wu, Y.H. Hsieh, Y.S. Hsieh, and J.Y. Liu Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma J. Cell. Biochem. 103 2008 9 20
32. G. Martiny-Baron, and D. Fabbro Classical PKC isoforms in cancer Pharmacol. Res. 55 2007 477 486
33. C.E. Antal, A.M. Hudson, E. Kang, C. Zanca, C. Wirth, N.L. Stephenson, E.W. Trotter, L.L. Gallegos, C.J. Miller, F.B. Furnari, T. Hunter, J. Brognard, and A.C. Newton Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor Cell 160 2015 489 502
34. J. Bruix, L. Boix, M. Sala, and J.M. Llovet Focus on hepatocellular carcinoma Cancer Cell 5 2004 215 219
35. A. Forner, M.I. Real, M. Varela, and J. Bruix Transarterial chemoembolization for patients with hepatocellular carcinoma Hepatol. Res. 37 2007 S230 S237
36. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc, A.C. de Oliveira, A. Santoro, J.L. Raoul, A. Forner, M. Schwartz, C. Porta, S. Zeuzem, L. Bolondi, T.F. Greten, P.R. Galle, J.F. Seitz, I. Borbath, D. Haussinger, T. Giannaris, M. Shan, M. Moscovici, D. Voliotis, J. Bruix, and S.I.S. Grp Sorafenib in advanced hepatocellular carcinoma N. Engl. J. Med. 359 2008 378 390
37. J.A. Kim, G.P. Neupane, E.S. Lee, B.S. Jeong, B.C. Park, and P. Thapa NADPH oxidase inhibitors: a patent review Expert Opin. Ther. Pat. 21 2011 1147 1158